| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 10 | |
| #2 | United States | 4 | |
| #3 | Japan | 3 | |
| #4 | Canada | 1 | |
| #5 | Hong Kong | 1 | |
| #6 | Hungary | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Organic fine chemistry | |
| #5 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Analysing materials | |
| #4 | Heterocyclic compounds | |
| #5 | Peptides | |
| #6 | Microorganisms | |
| #7 | Animal care | |
| #8 | Measuring microorganism processes | |
| #9 | Special acyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Austen Matthias | 7 |
| #2 | Onichtchouk Daria | 4 |
| #3 | Burk Ulrike | 4 |
| #4 | Pohlner Johannes | 4 |
| #5 | Von Der Kammer Heinz | 4 |
| #6 | Harder Friedrich | 3 |
| #7 | Schneider Martin | 3 |
| #8 | Heckel Armin | 2 |
| #9 | Blackaby Wesley | 2 |
| #10 | Black Phillip | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA2914525A1 | Sulfoximine substituted quinazolines for pharmaceutical compositions | |
| EP1644027A1 | Use of pleiotrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome | |
| EP2289908A1 | Use of DG177 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |